News

A recent study found that diseases such as systemic mastocytosis (SM) are a significant risk factor for adverse reactions to insect stings.

A recently published case report described an SM patient who underwent surgery with the addition of CytoSorb in the bypass system.

A recently published case report describes a patient with a combined diagnosis of systemic mastocytosis (SM) and myelodysplastic syndrome.

A recent case report described a patient with an uncommon presentation of SM that caused diagnostic challenges and resulted in a splenectomy.

The phase 2 Apex trial aiming to test bezuclastinib in patients with SM, has recently completed enrollment for part one of the trial.

A recently published study showed those with Hymenoptera venom allergy (HVA) should be screened for clonal mast cell diseases (CMD).

ARS Pharmaceuticals recently announced its nasal spray for type 1 allergic reactions has received FDA approval.

A recently published case study described a 4-year-old girl with both amyloid myeloid leukemia (AML) and systemic mastocytosis (SM).

A recent study found targeting eosinophils in nonadvanced SM may help those who have not found success with other treatments.

A recent study showed SM can be associated with severe complications and atypical symptoms, highlighting the need for a uniform diagnostic approach.